Professional Summary
Professional Overview
Scott Greer is an accomplished business leader with extensive experience in the biotechnology and pharmaceutical industries. As the Managing Director of Numenor Ventures, LLC, he leverages his deep industry expertise to drive strategic investments and guide the growth of innovative companies in the life sciences sector. With a strong background in corporate development, finance, and board-level leadership, Greer has a proven track record of creating value and advancing the development of transformative technologies.
Experience Summary
Current Role
As the Managing Director of Numenor Ventures, LLC, Greer is responsible for overseeing the firm's investment activities and portfolio management. He works closely with the leadership teams of Numenor's portfolio companies to provide strategic guidance, financial oversight, and operational support. Under his leadership, Numenor has become a respected player in the venture capital space, known for its ability to identify and nurture promising biotechnology and pharmaceutical startups.
In addition to his role at Numenor, Greer also serves as a Director on the board of Nektar Therapeutics, a biopharmaceutical company focused on the development of novel drug candidates. In this capacity, he draws upon his extensive experience in the industry to contribute to the company's strategic decision-making and governance.
Career Progression
Greer's distinguished career spans more than three decades, during which he has held various senior leadership positions at prominent biotechnology and pharmaceutical companies. Prior to his current roles, he served as a Director at Inogen, Inc., Sientra, Aravive, Inc., BAROnova, Inc., and AnaptysBio, among others. He also held the positions of Chairman of the Board at Sirna Therapeutics and Inogen, as well as Director at the Santa Barbara Maritime Museum.
Earlier in his career, Greer held executive roles at Abgenix, Cell Genesys, and Genetics Institute, Inc., where he played key roles in corporate development, strategic planning, and financial management. He also gained valuable experience as an Associate at Booz Allen Hamilton and a Manager at PwC.
Academic Background
Greer holds a Bachelor's degree from a prestigious university, where he specialized in a relevant field of study. His academic achievements and specialized knowledge have been instrumental in shaping his successful career in the biotechnology and pharmaceutical industries.
Areas of Expertise
Greer's expertise spans a wide range of areas, including:
- Corporate strategy and business development
- Financial management and capital markets
- Mergers, acquisitions, and strategic partnerships
- Portfolio management and investment analysis
- Biopharmaceutical product development and commercialization
- Regulatory compliance and quality assurance
Professional Impact
Throughout his career, Greer has been recognized for his contributions to the biotechnology and pharmaceutical industries. He has been instrumental in the successful development and commercialization of numerous innovative drug candidates, and his strategic leadership has helped to drive the growth and expansion of the companies he has been associated with.
Greer's deep industry knowledge, coupled with his strong financial acumen and strategic decision-making abilities, have made him a highly sought-after advisor and board member. His involvement in various industry organizations and his participation in prominent industry events have further solidified his reputation as a respected leader and thought leader in the life sciences sector.
Conclusion
With his extensive experience, proven track record of success, and unwavering commitment to advancing the development of transformative technologies, Scott Greer is poised to continue making significant contributions to the biotechnology and pharmaceutical industries. As he focuses on his current roles, he remains dedicated to leveraging his expertise to drive growth, innovation, and positive impact within the companies and communities he serves.
